{"id":"W4307178199","doi":"10.1002/cncr.34463","title":"A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Clinical endpoint; Adverse effect; Response Evaluation Criteria in Solid Tumors; Oncology; Univariate analysis; Phases of clinical research; Ipilimumab; Toxicity; Surgery; Cancer; Gastroenterology; Immunotherapy; Clinical trial; Multivariate analysis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001746972,0.001297149,0.001940837,0.000313051,0.0004633055,0.0008146891,0.0007671374,0.001097021,0.002842281],"category_scores_gemma":[0.00087617,0.0006294442,0.001272156,0.0002477875,0.0006998896,0.0006895163,0.0002673944,0.002765851,0.0007467332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001075709,"about_ca_system_score_gemma":0.00204705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001165348,"about_ca_topic_score_gemma":0.003497351,"domain_scores_codex":[0.9995896,0.0002018924,0.00002027296,0.00006698316,0.00004334404,0.0000778484],"domain_scores_gemma":[0.99935,0.00009315986,0.00008144874,0.0000545188,0.00007191097,0.0003489158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5776373,0.2169067,0.02177497,0.001237791,0.001980763,0.0006359056,0.0004926909,0.003154971,0.07055309,0.0002099323,0.004512767,0.1009031],"study_design_scores_gemma":[0.5487605,0.4265448,0.01603508,0.00003085732,0.0005105486,0.0003640018,0.00007525893,0.001771776,0.003833754,0.000102832,0.001942206,0.00002834291],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949398,0.0009673271,0.000278889,0.0002140481,0.00009829432,0.002251308,0.000422785,0.00003972256,0.0007877555],"genre_scores_gemma":[0.992255,0.0009836279,0.00131229,0.0006166049,0.0001402435,0.002161736,0.001101141,0.00001932137,0.001410136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002842281,"threshold_uncertainty_score":0.009508371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01682327207268034,"score_gpt":0.2889173040255949,"score_spread":0.2720940319529145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}